Century Therapeutics, Inc. (IPSC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$41.27M2021: -$89.00M2022: $14.05M2023: -$88.35M2024: -$110.14M2025: -$103.88M-$103.88M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$103.88M+5.7%
2024-$110.14M-24.7%
2023-$88.35M-728.7%
2022$14.05M+115.8%
2021-$89.00M-115.7%
2020-$41.27M